Cargando…

LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis

Detalles Bibliográficos
Autor principal: Kumar, Gautam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961436/
https://www.ncbi.nlm.nih.gov/pubmed/31983834
http://dx.doi.org/10.4103/iju.IJU_258_19
_version_ 1783487993233801216
author Kumar, Gautam
author_facet Kumar, Gautam
author_sort Kumar, Gautam
collection PubMed
description
format Online
Article
Text
id pubmed-6961436
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-69614362020-01-24 LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis Kumar, Gautam Indian J Urol Uroscan Wolters Kluwer - Medknow 2020 /pmc/articles/PMC6961436/ /pubmed/31983834 http://dx.doi.org/10.4103/iju.IJU_258_19 Text en Copyright: © 2020 Indian Journal of Urology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Uroscan
Kumar, Gautam
LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis
title LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis
title_full LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis
title_fullStr LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis
title_full_unstemmed LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis
title_short LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis
title_sort latitude: a landmark trial for high-risk metastatic castration-sensitive prostate cancer: final overall survival analysis
topic Uroscan
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961436/
https://www.ncbi.nlm.nih.gov/pubmed/31983834
http://dx.doi.org/10.4103/iju.IJU_258_19
work_keys_str_mv AT kumargautam latitudealandmarktrialforhighriskmetastaticcastrationsensitiveprostatecancerfinaloverallsurvivalanalysis